The CONSUL trial by Dr Proft et al. compared impact of CEL+GOL vs. GOL alone on radiographic spinal progression in AS showed no significant difference bet. the 2 grps in mSASSS change after 108 wks. Risk stratify pts who will benefit from tx #ACR22 @RheumNow ABST#0546 #ACRBest https://t.co/jWwX7w85ur